These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8200229

  • 1. Relationship among p53, stage, and prognosis of large bowel cancer.
    Nathanson SD, Linden MD, Tender P, Zarbo RJ, Jacobsen G, Nelson LT.
    Dis Colon Rectum; 1994 Jun; 37(6):527-34. PubMed ID: 8200229
    [Abstract] [Full Text] [Related]

  • 2. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
    Gervaz P, Bouzourene H, Cerottini JP, Chaubert P, Benhattar J, Secic M, Wexner S, Givel JC, Belin B.
    Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
    [Abstract] [Full Text] [Related]

  • 3. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma.
    Suzuki H, Matsumoto K, Koide A, Tada T, Fujino I, Okuda A, Shigemori C.
    Surg Today; 1994 Mar; 24(1):85-7. PubMed ID: 8054784
    [Abstract] [Full Text] [Related]

  • 4. Cyclin E, p27 and mutant p53 do not predict the prognosis in AJCC stage II colorectal carcinomas.
    Lim YJ, Kim YH, Ahn GH, Chun HK, Jang WY, Lee JH, Son HJ, Rhee PL, Kim JJ, Paik SW, Yoo BC, Rhee JC.
    Korean J Gastroenterol; 2004 Dec; 44(6):314-20. PubMed ID: 15665575
    [Abstract] [Full Text] [Related]

  • 5. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.
    Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH.
    J Natl Cancer Inst; 1992 Jun 03; 84(11):845-55. PubMed ID: 1317462
    [Abstract] [Full Text] [Related]

  • 6. Clinico-pathological correlation and prognostic significance of nuclear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena.
    Fante R, Di Gregorio C, Losi L, Roncucci L, Ponz de Leon M.
    Ital J Gastroenterol; 1996 May 03; 28(4):205-10. PubMed ID: 8842835
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combination of p53 expression and p21 loss has an independent prognostic impact on sporadic colorectal cancer.
    Noske A, Lipka S, Budczies J, Müller K, Loddenkemper C, Buhr HJ, Kruschewski M.
    Oncol Rep; 2009 Jul 03; 22(1):3-9. PubMed ID: 19513497
    [Abstract] [Full Text] [Related]

  • 9. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
    Grizzle WE, Manne U, Weiss HL, Jhala N, Talley L.
    Int J Cancer; 2002 Feb 01; 97(4):403-9. PubMed ID: 11802199
    [Abstract] [Full Text] [Related]

  • 10. p53 accumulation associated with bcl-2, the proliferation marker MIB-1 and survival in patients with prostate cancer subjected to watchful waiting.
    Borre M, Stausbol-Gron B, Overgaard J.
    J Urol; 2000 Sep 01; 164(3 Pt 1):716-21. PubMed ID: 10953132
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
    Giatromanolaki A, Stathopoulos GP, Tsiompanou E, Papadimitriou C, Georgoulias V, Gatter KC, Harris AL, Koukourakis MI.
    Cancer; 1999 Oct 15; 86(8):1421-30. PubMed ID: 10526268
    [Abstract] [Full Text] [Related]

  • 13. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
    Diez M, Medrano M, Mugüerza JM, Ramos P, Hernandez P, Villeta R, Martín A, Noguerales F, Ruiz A, Granell J.
    Anticancer Res; 2000 Oct 15; 20(5C):3907-12. PubMed ID: 11268475
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma.
    Zhang Hong.
    Clin Cancer Res; 1999 Dec 15; 5(12):4126-32. PubMed ID: 10632350
    [Abstract] [Full Text] [Related]

  • 17. [P53 protein in adenocarcinoma of the large intestine].
    Paluszkiewicz P, Pawłowska-Wakowicz B, Cybulski M, Berbeć H.
    Wiad Lek; 1997 Dec 15; 50 Suppl 1 Pt 1():87-91. PubMed ID: 9446410
    [Abstract] [Full Text] [Related]

  • 18. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H, Gervaz P, Cerottini JP, Benhattar J, Chaubert P, Saraga E, Pampallona S, Bosman FT, Givel JC.
    Eur J Cancer; 2000 May 15; 36(8):1008-15. PubMed ID: 10885605
    [Abstract] [Full Text] [Related]

  • 19. Mutant p53 protein as a predictor of survival in endometrial carcinoma.
    Strang P, Nordstöm B, Nilsson S, Bergström R, Tribukait B.
    Eur J Cancer; 1996 Apr 15; 32A(4):598-602. PubMed ID: 8695259
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.